• A unique Pharmaceutical Company

    Orphan Europe, part of the Recordati group, is a unique pharmaceutical company focusing on the research and development of orphan medicinal products. Since 1990 we have used big thinking and extensive know-how on behalf of people affected by rare diseases. Patients and their families are central to our planning, our thinking and our actions. Recordati orphan drugs is present in the USA through its company Recordati Rare Diseases.

  • Big thinking for people with rare diseases

    Everything we do is driven by the needs of people who have a rare disease

  • Patients and families

    Orphan Europe is committed to establishing strong alliances with patients and patient organisations worldwide, to achieve the common goal of building knowledge and awareness, improving diagnosis, access to treatment and prevention of rare diseases.

  • Current products and pipeline

    Orphan Europe is a leading pharmaceutical company dedicated to the development of orphan medicinal products.

  • Collaboration

    At Orphan Europe, we're committed to improving the diagnosis and management of rare diseases.

  • Our responsibilities

    As part of our commitment to rare diseases, Orphan Europe has partnered and supports various programmes and activities

  • Recordati Rare Diseases Foundation

    Advancing knowledge in rare diseases: independent, professional education and training

  • Partnering with Orphan Europe

    Orphan Europe has developed successful partnerships with a number of well-established pharmaceutical and biotechnology companies and research institutes.

  • Pharmacovigilance at Orphan Europe

    aims to enhance patient care and patient safety in relation to the use of our drugs. We support public health programs by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines.

  • We take the Rare Disease Day® personally

    Created in 2008 by Eurordis, the Rare Disease Day® gathers thousand of events around the world to raise awareness for rare diseases and their impact on the lives of patients and their families.

News and events

Orphan Europe is pleased to launch the Homocystinurias-in-child-neuro.com website

Orphan Europe is pleased to invite healthcare professionals to participate in a Webcast entitled “Echo Assessment of PDA”, the 26th of November from 3 to 4PM (CET time)

Orphan Europe is delighted to invite the scientific community in participating in the 12th Middle East Metabolic Group in Mascate (Oman), from the 29th of October to the 1st of November 2015.

More than ever before, Orphan Europe is involved in the care of preterm babies affected by Patent Ductus Arteriosus.

About us

Corporate Brochure,